Back to Journals » International Journal of Women's Health » Volume 12

Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis

Authors Sharman Moser S, Chodick G, Bar-On S, Shalev V

Received 15 January 2020

Accepted for publication 17 April 2020

Published 3 June 2020 Volume 2020:12 Pages 445—454


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Professor Elie Al-Chaer

Sarah Sharman Moser,1 Gabriel Chodick,1,2 Shikma Bar-On,3 Varda Shalev1,2

1Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel Aviv, Israel; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 3Lis Maternity Hospital, Tel-Aviv Medical Center, Tel-Aviv, Israel

Correspondence: Sarah Sharman Moser
Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, 27 Hamered St, Tel Aviv 6812509, Israel
Tel +972-37462778

Objective: Self-reported studies estimated that as many as 50– 75% of women experience symptoms during menopause; however, limited real-world clinical data are available to support this observation. The electronic databases of Maccabi Healthcare Services were used to describe the prevalence of menopause symptoms in Israel and to characterize patients with regard to socioeconomic status, comorbidities and use of healthcare services.
Methods: Females aged 45– 54 years diagnosed with menopausal symptoms (N=17,046, cumulative incidence of 8% during the study period) were identified from the Maccabi Healthcare Services electronic database and matched to female members without menopause symptoms, one-to-one on birth year and enumeration area.
Results: Symptomatic peri- and post-menopausal women, and particularly those under 52 years, were more likely to have a higher prevalence of comorbid conditions such as depression, anxiety, osteoporosis and insomnia in the year following index. Correspondingly, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors and hypnotic drug use were significantly higher in symptomatic women as was healthcare utilization including hospitalization (OR=1.10; 95% CI=1.00– 1.20), primary care visits (1.90; 1.73– 2.08), gynecologist visits (24.84; 22.36– 27.59) and hysterectomy procedures (2.26; 1.63– 3.14).
Conclusion: Medically documented menopausal symptoms are associated with increased burden of disease (particularly among women diagnosed with menopausal symptoms prior to age 52 years), healthcare utilization and greater likelihood of undergoing hysterectomy within one year of diagnosis. This burden is expected to rise further as awareness and social acceptance of peri- and post-menopausal symptoms increase.

Keywords: menopause, peri-menopause, real-world study, healthcare utilization

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]